Transdermal drug delivery systems and skin sensitivity reactions. Incidence and management.
about
Skin tolerability of transdermal patches.Challenges and opportunities in dermal/transdermal delivery.Side effects of using nitrates to treat angina.The effects of clonidine on symptoms and anorectal sensorimotor function in women with faecal incontinence.Administration of substances to laboratory animals: routes of administration and factors to consider.Transdermal patches: history, development and pharmacology.Dermal and transdermal drug delivery systems: current and future prospects.Multicenter clinical study for evaluation of efficacy and safety of transdermal fentanyl matrix patch in treatment of moderate to severe cancer pain in 474 chinese cancer patients.Topical herbal application as an adjuvant treatment for chronic kidney disease--a systematic review of randomized controlled clinical trials.Permeation enhancer strategies in transdermal drug delivery.Comparison of efficacy and local tolerability of estradiol metered-dose transdermal spray to estradiol patch in a network meta-analysis.Design, Development, and Optimization of Dexibuprofen Microemulsion Based Transdermal Reservoir Patches for Controlled Drug Delivery.A one year health economic model comparing transdermal fentanyl with sustained-release morphine in the treatment of chronic noncancer pain.Outcomes of acute dermal irritation and sensitisation tests on active dressings for chronic wounds: a comparative study.Efficacy and safety of long-acting intramuscular testosterone undecanoate in aging men: a randomised controlled study.
P2860
Q30318415-EBE3E6C4-0647-415F-B005-04C3A572D996Q30432573-8E4F9E0B-AB4B-4BB8-BDED-004672C5D179Q33154151-3E6C3DA1-AC62-48D7-9F6C-01B29504BE8AQ34101459-9A808648-361E-47FC-AA69-72B90DDC0A74Q35295915-A3BE6C34-3BE6-465C-98D4-B6967711642AQ35484265-DD8E8189-90AC-4CC7-9690-2A189821DA3BQ36429878-0310BF3F-085B-4C91-A745-7603DD5430BFQ36551093-AEAD4D74-AB93-4E4E-AE82-EF15E4AC39F2Q37974261-DEE7B1B1-D53B-43F1-8A8E-F44E00DB7A13Q38227590-15ACD2BF-38EA-45DF-9ED5-ABA80D2701B0Q38946055-D61E4F3B-689B-43D8-86BD-DC2FA3106FC4Q42705880-3EE203E6-1B59-4E01-8DC8-7AD45C3E745EQ44676134-FC3BF8EC-C5C9-49BB-9583-5ED948CD9CE2Q46744371-30AB990A-156A-4ED6-B929-FB43EC976921Q51013519-584F69C3-4B00-446A-A278-7D4A019A9217
P2860
Transdermal drug delivery systems and skin sensitivity reactions. Incidence and management.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Transdermal drug delivery syst ...... ons. Incidence and management.
@ast
Transdermal drug delivery syst ...... ons. Incidence and management.
@en
Transdermal drug delivery syst ...... ons. Incidence and management.
@nl
type
label
Transdermal drug delivery syst ...... ons. Incidence and management.
@ast
Transdermal drug delivery syst ...... ons. Incidence and management.
@en
Transdermal drug delivery syst ...... ons. Incidence and management.
@nl
prefLabel
Transdermal drug delivery syst ...... ons. Incidence and management.
@ast
Transdermal drug delivery syst ...... ons. Incidence and management.
@en
Transdermal drug delivery syst ...... ons. Incidence and management.
@nl
P1476
Transdermal drug delivery syst ...... ons. Incidence and management.
@en
P2093
Carmichael AJ
P304
P356
10.2165/00128071-200001060-00004
P577
2000-11-01T00:00:00Z
P6179
1040960592